Adma Biologics (ADMA) concluded the recent trading session at $18.34, signifying a +2.98% move from ...
Principal Financial Group Inc. boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free...
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The ove...
Penserra Capital Management LLC bought a new stake in shares of ADMA Biologics Inc (NASDAQ:ADMA - Fr...
ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, presents a compelling c...